<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>To identify factors related to the development of <z:hpo ids='HP_0003774'>end-stage renal disease</z:hpo> after the <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:hpo ids='HP_0000093'>proteinuria</z:hpo>, its incidence was determined in 364 Pima Indians aged 35 years or older with Type 2 (non-insulin-dependent) <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> and <z:hpo ids='HP_0000093'>proteinuria</z:hpo> (protein-to-<z:chebi fb="0" ids="16737">creatinine</z:chebi> ratio &gt; or = 0.5 g/g) </plain></SENT>
<SENT sid="1" pm="."><plain>Of these 364 subjects, 95 (36 men, 59 women) developed <z:hpo ids='HP_0003774'>end-stage renal disease</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>The cumulative incidence was 40% 10 years after and 61% 15 years after the <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:hpo ids='HP_0000093'>proteinuria</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>The incidence of <z:hpo ids='HP_0003774'>end-stage renal disease</z:hpo> was significantly related to the duration of <z:mp ids='MP_0002055'>diabetes</z:mp>, the duration of <z:hpo ids='HP_0000093'>proteinuria</z:hpo>, higher 2-h plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> concentration, type of <z:mp ids='MP_0002055'>diabetes</z:mp> treatment, and the presence of <z:hpo ids='HP_0000488'>retinopathy</z:hpo> at the time of recognition of the <z:hpo ids='HP_0000093'>proteinuria</z:hpo>, but not to age, sex, or blood pressure </plain></SENT>
<SENT sid="4" pm="."><plain>Duration of <z:hpo ids='HP_0000093'>proteinuria</z:hpo> influenced the risk of <z:hpo ids='HP_0003774'>end-stage renal disease</z:hpo>, contingent, however, upon the duration of <z:mp ids='MP_0002055'>diabetes</z:mp> at the <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:hpo ids='HP_0000093'>proteinuria</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>The higher cumulative incidence of <z:hpo ids='HP_0003774'>end-stage renal disease</z:hpo> 15 years after the <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:hpo ids='HP_0000093'>proteinuria</z:hpo> in Pima Indians (61%) than in Caucasians from Rochester, Minnesota (17%) may be attributable, in part, to the younger <z:hpo ids='HP_0011007'>age of onset</z:hpo> of Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> in Pima Indians than in Caucasians, to ethnic differences in susceptibility to <z:e sem="disease" ids="C0022658" disease_type="Disease or Syndrome" abbrv="">renal disease</z:e>, or to lower <z:hpo ids='HP_0011420'>death</z:hpo> rates among the Pima Indians from competing causes of <z:hpo ids='HP_0011420'>death</z:hpo>, such as <z:e sem="disease" ids="C0010068" disease_type="Disease or Syndrome" abbrv="">coronary heart disease</z:e> </plain></SENT>
</text></document>